Pralidoxime Cl (Pralidoxime Chloride Vials) 1gm + WFI

Pralidoxime chloride 1gm vials are used alongside atropine to treat organophosphate poisoning by reactivating cholinesterase. These vials contain 1 gram of pralidoxime chloride with water for injection. Suitable for emergency medical settings.

Strength

1gm + WFI

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Troikaa Pharmaceuticals Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pralidoxime chloride 1gm vials are indicated for the treatment of poisoning caused by organophosphate pesticides or nerve agents. They work by reactivating acetylcholinesterase, an enzyme inhibited by organophosphates. This helps restore normal nerve function and reduce symptoms of poisoning. Often used in combination with atropine for comprehensive treatment.

Side Effects

Pralidoxime chloride may help reduce muscle weakness, difficulty breathing, and other symptoms caused by organophosphate poisoning. It works by reversing the effects of the poison on the nervous system. Effects vary depending on how quickly treatment is administered after exposure.

Precautions & Warnings

Pralidoxime chloride should be handled and administered by trained medical professionals. It is not intended for self-administration. Ensure proper storage at room temperature and check for clarity and particulate matter before use. Discard if the solution is discolored or contains particles.

Avoid Interactions

Pralidoxime chloride may interact with other medications affecting the nervous system, such as muscle relaxants or certain anesthetics. Alcohol and other central nervous system depressants should be avoided during treatment. Always inform healthcare providers of all medications and conditions before administration.

References

Frequently Asked Questions

Pralidoxime chloride is used to treat poisoning from organophosphate pesticides or nerve agents by reactivating cholinesterase.

It is typically administered by intravenous injection in a clinical setting by trained medical personnel.

No, it should only be used under medical supervision in a healthcare facility.

Common effects may include dizziness, blurred vision, or mild pain at the injection site.

Consult a healthcare provider; safety during pregnancy has not been fully established.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.